Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria
Introduction Lassa fever (LF) is a severe and often fatal systemic disease in humans and affects a large number of countries in West Africa. Treatment options are limited to supportive care and the broad-spectrum antiviral agent ribavirin. However, evidence for ribavirin efficacy in patients with LF...
Saved in:
| Main Authors: | Michael Ramharter, Osahogie Edeawe, Peter Akhideno, Gloria Eifediyi, Till F Omansen, Christine Wagner, Francisca Sarpong, Till Koch, Sebastian Wicha, Florian Kurth, Sophie Duraffour, Lisa Oestereich, Meike Pahlmann, Sylvanus Okogbenin, Ephraim Ogbaini-Emovon, Stephan Günther, Mirjam Groger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-04-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/4/e036936.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
by: Suzanne Penfold, et al.
Published: (2023-01-01) -
Motorcycle Related Injuries among Rural Dwellers in Irrua, Nigeria: Characteristics and Correlates
by: A. E. Dongo, et al.
Published: (2013-01-01) -
Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
by: Suzanne Penfold, et al.
Published: (2025-01-01) -
Lassa virus in novel hosts: insights into the epidemiology of lassa virus infections in southern Nigeria
by: Anise Nkenjop Happi, et al.
Published: (2024-12-01) -
Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin
by: Hirokazu Suii, et al.
Published: (2017-01-01)